Inventor
PATTERSON LORI JEAN
US32 patents
⚠️ This page may combine multiple inventors who share the name “PATTERSON LORI JEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
11 patentsUS10722504B2Jul 28, 2020
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC5 citations93
US10441579B2Oct 15, 2019
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC7 citations93
US10206913B2Feb 19, 2019
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC11 citations93
US10034870B2Jul 31, 2018
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC12 citations93
US10576073B2Mar 3, 2020
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
THERAVANCE BIOPHARMA R&D IP LLC6 citations92
US10226454B2Mar 12, 2019
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
THERAVANCE BIOPHARMA R&D IP LLC8 citations92
US10946007B2Mar 16, 2021
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US10946006B2Mar 16, 2021
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
THERAVANCE BIOPHARMA R&D IP LLC4 citations84
US12239638B2Mar 4, 2025
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
THERAVANCE BIOPHARMA R&D IP LLC0 citations73
US11723900B2Aug 15, 2023
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
THERAVANCE BIOPHARMA R&D IP LLC0 citations73
US11596624B2Mar 7, 2023
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
THERAVANCE BIOPHARMA R&D IP LLC1 citations73
STANGELAND ERIC L
9 patentsUS9012460B2Apr 21, 2015
1-(2-phenoxymethylphenyl)piperazine compounds
STANGELAND ERIC L7 citations84
US8778949B2Jul 15, 2014
1-(2-phenoxymethylphenyl)piperazine compounds
STANGELAND ERIC L7 citations84
US8530663B2Sep 10, 2013
1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
STANGELAND ERIC L8 citations84
US8242164B2Aug 14, 2012
3-(phenoxyphenylmethyl)pyrrolidine compounds
STANGELAND ERIC L9 citations84
US8471040B2Jun 25, 2013
Serotonin reuptake inhibitors
STANGELAND ERIC L3 citations63
US9000191B2Apr 7, 2015
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
US8933249B2Jan 13, 2015
3-(phenoxyphenylmethyl)pyrrolidine compounds
STANGELAND ERIC L0 citations52
US8853255B2Oct 7, 2014
3-phenoxymethylpyrrolidine compounds
STANGELAND ERIC L0 citations52
US8729119B2May 20, 2014
Serotonin reuptake inhibitors
STANGELAND ERIC L0 citations52
PATTERSON LORI JEAN
6 patentsUS9675599B2Jun 13, 2017
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN17 citations96
US9162982B2Oct 20, 2015
4-[2-(2-fluorophenoxy methyl)phenyl]piperidine compounds
PATTERSON LORI JEAN15 citations96
US9073859B2Jul 7, 2015
Crystalline form of a 4-[2-(2-fluorophenoxymethyl) phenyl]piperidine compound
PATTERSON LORI JEAN18 citations96
US8604058B2Dec 10, 2013
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN20 citations96
US8304433B2Nov 6, 2012
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
PATTERSON LORI JEAN23 citations96
US8304432B2Nov 6, 2012
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
PATTERSON LORI JEAN25 citations96
THERAVANCE INC
3 patentsUS8592596B2Nov 26, 2013
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
THERAVANCE INC15 citations92
US7994209B2Aug 9, 2011
3-phenoxymethylpyrrolidine compounds
THERAVANCE INC14 citations92
US7888386B2Feb 15, 2011
3-(phenoxyphenylmethyl)pyrrolidine compounds
THERAVANCE INC30 citations92